T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 8.34 CNY -4.58% Market Closed
Market Cap: 16.3B CNY
Have any thoughts about
Tonghua Dongbao Pharmaceutical Co Ltd?
Write Note

Tonghua Dongbao Pharmaceutical Co Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tonghua Dongbao Pharmaceutical Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
T
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Total Current Liabilities
ÂĄ406.8m
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
-2%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Current Liabilities
ÂĄ6.9B
CAGR 3-Years
37%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Current Liabilities
ÂĄ2.5B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
27%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Current Liabilities
ÂĄ4.8B
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Current Liabilities
ÂĄ13.8B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
14%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Current Liabilities
ÂĄ1.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tonghua Dongbao Pharmaceutical Co Ltd
Glance View

Market Cap
16.5B CNY
Industry
Pharmaceuticals

Tonghua Dongbao Pharmaceutical Co., Ltd. is engaged in the manufacture, distribution, research and development of pharmaceuticals. The company is headquartered in Tonghua, Jilin and currently employs 2,814 full-time employees. The firm provides biological products, traditional Chinese medicines and chemical supplements, applied in the treatment of diabetes and cardiovascular and cerebrovascular diseases, among others. The firm's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules, among others. The firm also provides medical instruments, plastic-steel windows and profiles, and operates property business. The firm distributes its products within domestic markets and to overseas markets.

Intrinsic Value
10.09 CNY
Undervaluation 17%
Intrinsic Value
Price
T

See Also

What is Tonghua Dongbao Pharmaceutical Co Ltd's Total Current Liabilities?
Total Current Liabilities
406.8m CNY

Based on the financial report for Sep 30, 2024, Tonghua Dongbao Pharmaceutical Co Ltd's Total Current Liabilities amounts to 406.8m CNY.

What is Tonghua Dongbao Pharmaceutical Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
-2%

Over the last year, the Total Current Liabilities growth was 22%. The average annual Total Current Liabilities growth rates for Tonghua Dongbao Pharmaceutical Co Ltd have been 12% over the past three years , 7% over the past five years , and -2% over the past ten years .

Back to Top